Q-Immune, Inc.

BiotechnologyBiotechnologyCell TherapyPlatform

📍 Seattle, WA, United States

StreetZero Signal 62

Be the first to signal interest

About Q-Immune, Inc.

Q-Immune, Inc. develops QMI technology that reads cell signals to program safer cell therapies. The company focuses on applications in oncology, autoimmune diseases, and neuroscience. It is a member of the NVIDIA Inception program and collaborates with Seattle Children’s Hospital. Its primary website is qimmune.com and it is headquartered in Seattle, WA.

LATEST FUNDINGPrivate Placement

$25K

Announced 2026-09-28

TOTAL RAISED$25,000

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Q-Immune, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQSeattle, WA, United States

Industry

Biotechnology

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Q-Immune develops QMI technology to decode cell signals for safer cell therapies.
The company targets oncology, autoimmune, and neuroscience indications.
It participates in the NVIDIA Inception program and partners with Seattle Children’s.
A $25,000 private placement was filed with location listed as Seattle, WA.